IRF4 and neoplasm: CRISPR screens have discovered that TOX can promote CD8 + T cell exhaustion in collaboration with NR4A, and TOX serves as a significant downstream regulatory molecule reversing tumour-infiltrating T cell exhaustion with BATF and IRF4, which were the hits in several CRISPR screenings [129].